Furthermore, E2F transcription factors, from E2F1 to E2F8, have been reported as possible biomarkers for breast cancer [71,72,73], although their expression patterns and prognostic significance have been inconsistent in previous studies [73,74,75,76,77,78,79]. This evidence concerns the gene E2F8 and breast cancer.